Company profile
ADC Therapeutics company profile
ADC Therapeutics is a clinical-stage oncology drug discovery and development company focused on advancing highly potent and targeted antibody-drug conjugates (ADCs) for the treatment of hematological cancers and solid tumors. Their ADCs are developed using the latest-generation pyrrolobenzodiazepine (PBD) dimer technology providing a superior therapeutic index compared to first-generation PBD ADCs in preclinical studies. PBD dimers are very potent toxins that actively kill cancer cells and have a differentiated mechanism of action than warheads commonly used in other ADCs.
Business identity
- Contact email
- [email protected]
- Phone number
- +1 908-731-5556
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00251-00500 employees
- Revenue range
- $50K+
- Founded
- 2011-01-01
Headquarters
- Headquarters
- Malters, Lucerne, Switzerland
- Postal code
- 1066
- Country code
- CH
- Continent
- Europe